Product NDC: | 52533-202 |
Proprietary Name: | Ipratropium Bromide |
Non Proprietary Name: | Ipratropium Bromide |
Active Ingredient(s): | .5 mg/mL & nbsp; Ipratropium Bromide |
Administration Route(s): | RESPIRATORY (INHALATION) |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52533-202 |
Labeler Name: | Cantrell Drug Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 20121012 |
Package NDC: | 52533-202-45 |
Package Description: | 1 mL in 1 SYRINGE, PLASTIC (52533-202-45) |
NDC Code | 52533-202-45 |
Proprietary Name | Ipratropium Bromide |
Package Description | 1 mL in 1 SYRINGE, PLASTIC (52533-202-45) |
Product NDC | 52533-202 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ipratropium Bromide |
Dosage Form Name | SOLUTION |
Route Name | RESPIRATORY (INHALATION) |
Start Marketing Date | 20121012 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | Cantrell Drug Company |
Substance Name | IPRATROPIUM BROMIDE |
Strength Number | .5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Anticholinergic [EPC],Cholinergic Antagonists [MoA] |